63/100B255.59
USD
0.87
(0.34%)
Pre Open
Fair value202.30Plus+26%77Price 255.59264
Q4 FY2026 · Earnings report
EPS estimate 2.68Revenue estimate 3.04B
Q4 FY2026 · Earnings report
EPS estimate 2.68Revenue estimate 3.04B
Quest Diagnostics price to sales (P/S) ratioWhat is the P/S ratio? The price-to-sales ratio compares a company's market value with its revenue over the last year: what you pay for each dollar of sales.
Quest Diagnostics's P/S ratio is 2.38: its market cap of 28.21B USD over revenue of 11.84B USD in the last twelve months.
- Today
- 2.38
- Average, 5 years
- 1.75
- Low, 5 years
- 1.35
- High, 5 years
- 2.38
P/S ratio = market cap ÷ revenue (last 12 months) = 28.21B ÷ 11.84B = 2.38
Each day's market cap over the revenue of the last four quarters reported by that day.
P/S ratio by year and by quarter
| Fiscal year | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Today | 2.38 | 28.21B | 11.84B | |
| FY2025 | 31 Dec 2025 | 1.75 | 19.26B | 11.04B |
| FY2024 | 31 Dec 2024 | 1.70 | 16.75B | 9.87B |
| FY2023 | 31 Dec 2023 | 1.67 | 15.44B | 9.25B |
| FY2022 | 31 Dec 2022 | 1.84 | 18.15B | 9.88B |
| FY2021 | 31 Dec 2021 | 2.00 | 21.63B | 10.79B |
| FY2020 | 31 Dec 2020 | 1.69 | 15.97B | 9.44B |
| FY2019 | 31 Dec 2019 | 1.85 | 14.31B | 7.73B |
| FY2018 | 31 Dec 2018 | 1.50 | 11.32B | 7.53B |
| FY2017 | 31 Dec 2017 | 1.75 | 13.49B | 7.71B |
| FY2016 | 31 Dec 2016 | 1.71 | 12.87B | 7.52B |
| FY2015 | 31 Dec 2015 | 1.37 | 10.24B | 7.49B |
| FY2014 | 31 Dec 2014 | 1.31 | 9.72B | 7.44B |
| FY2013 | 31 Dec 2013 | 1.14 | 8.14B | 7.15B |
| FY2012 | 31 Dec 2012 | 1.25 | 9.24B | 7.38B |
| FY2011 | 31 Dec 2011 | 1.23 | 9.21B | 7.51B |
| FY2010 | 31 Dec 2010 | 1.29 | 9.48B | 7.37B |
| FY2009 | 31 Dec 2009 | 1.51 | 11.22B | 7.46B |
| FY2008 | 31 Dec 2008 | 1.39 | 10.09B | 7.25B |
| FY2007 | 31 Dec 2007 | 1.52 | 10.22B | 6.70B |
| FY2006 | 31 Dec 2006 | 1.67 | 10.44B | 6.27B |
| FY2005 | 31 Dec 2005 | 1.89 | 10.39B | 5.50B |
| FY2004 | 31 Dec 2004 | 1.90 | 9.74B | 5.13B |
| FY2003 | 31 Dec 2003 | 1.60 | 7.57B | 4.74B |
| FY2002 | 31 Dec 2002 | 1.34 | 5.49B | 4.11B |
| FY2001 | 31 Dec 2001 | 1.84 | 6.69B | 3.63B |
| FY2000 | 31 Dec 2000 | 1.86 | 6.36B | 3.42B |
| FY1999 | 31 Dec 1999 | 0.47 | 1.04B | 2.21B |
| FY1998 | 31 Dec 1998 | 0.36 | 532.02M | 1.46B |
| FY1997 | 31 Dec 1997 | 0.32 | 488.86M | 1.53B |
| FY1996 | 31 Dec 1996 | 0.27 | 443.97M | 1.62B |
| Quarter | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 2.17 | 25.64B | 11.84B |
| Q2 FY2026 | 30 Jun 2026 | 2.02 | 23.31B | 11.56B |
| Q1 FY2026 | 31 Mar 2026 | 1.91 | 21.56B | 11.28B |
| Q4 FY2025 | 31 Dec 2025 | 1.75 | 19.26B | 11.04B |
| Q3 FY2025 | 30 Sept 2025 | 1.97 | 21.34B | 10.85B |
| Q2 FY2025 | 30 Jun 2025 | 1.91 | 20.12B | 10.52B |
| Q1 FY2025 | 31 Mar 2025 | 1.85 | 18.78B | 10.16B |
| Q4 FY2024 | 31 Dec 2024 | 1.70 | 16.75B | 9.87B |
| Q3 FY2024 | 30 Sept 2024 | 1.82 | 17.39B | 9.54B |
| Q2 FY2024 | 30 Jun 2024 | 1.63 | 15.22B | 9.35B |
| Q1 FY2024 | 31 Mar 2024 | 1.61 | 14.96B | 9.29B |
| Q4 FY2023 | 31 Dec 2023 | 1.67 | 15.44B | 9.25B |
| Q3 FY2023 | 30 Sept 2023 | 1.47 | 13.65B | 9.30B |
| Q2 FY2023 | 30 Jun 2023 | 1.66 | 15.74B | 9.49B |
| Q1 FY2023 | 31 Mar 2023 | 1.65 | 15.85B | 9.60B |
| Q4 FY2022 | 31 Dec 2022 | 1.79 | 17.68B | 9.88B |
| Q3 FY2022 | 30 Sept 2022 | 1.38 | 14.23B | 10.29B |
| Q2 FY2022 | 30 Jun 2022 | 1.47 | 15.56B | 10.58B |
| Q1 FY2022 | 31 Mar 2022 | 1.53 | 16.29B | 10.68B |
| Q4 FY2021 | 31 Dec 2021 | 1.96 | 21.11B | 10.79B |
| Q3 FY2021 | 30 Sept 2021 | 1.62 | 17.87B | 11.05B |
| Q2 FY2021 | 30 Jun 2021 | 1.49 | 16.50B | 11.06B |
| Q1 FY2021 | 31 Mar 2021 | 1.65 | 17.07B | 10.34B |
| Q4 FY2020 | 31 Dec 2020 | 1.70 | 16.09B | 9.44B |
| Q3 FY2020 | 30 Sept 2020 | 1.85 | 15.46B | 8.36B |
| Q2 FY2020 | 30 Jun 2020 | 2.03 | 15.27B | 7.53B |
| Q1 FY2020 | 31 Mar 2020 | 1.41 | 10.76B | 7.66B |
| Q4 FY2019 | 31 Dec 2019 | 1.85 | 14.31B | 7.73B |
| Q3 FY2019 | 30 Sept 2019 | 1.89 | 14.45B | 7.64B |
| Q2 FY2019 | 30 Jun 2019 | 1.83 | 13.83B | 7.57B |
| Q1 FY2019 | 31 Mar 2019 | 1.60 | 12.08B | 7.54B |
| Q4 FY2018 | 31 Dec 2018 | 1.50 | 11.32B | 7.53B |
| Q3 FY2018 | 30 Sept 2018 | 1.93 | 14.74B | 7.63B |
| Q2 FY2018 | 30 Jun 2018 | 1.95 | 14.95B | 7.67B |
| Q1 FY2018 | 31 Mar 2018 | 1.77 | 13.64B | 7.69B |
| Q4 FY2017 | 31 Dec 2017 | 1.74 | 13.39B | 7.71B |
| Q3 FY2017 | 30 Sept 2017 | 1.68 | 12.83B | 7.63B |
| Q2 FY2017 | 30 Jun 2017 | 2.01 | 15.23B | 7.59B |
| Q1 FY2017 | 31 Mar 2017 | 1.78 | 13.45B | 7.55B |
| Q4 FY2016 | 31 Dec 2016 | 1.69 | 12.68B | 7.52B |
| Q3 FY2016 | 30 Sept 2016 | 1.57 | 11.76B | 7.50B |
| Q2 FY2016 | 30 Jun 2016 | 1.52 | 11.40B | 7.50B |
| Q1 FY2016 | 31 Mar 2016 | 1.36 | 10.22B | 7.52B |
| Q4 FY2015 | 31 Dec 2015 | 1.36 | 10.17B | 7.49B |
| Q3 FY2015 | 30 Sept 2015 | 1.18 | 8.85B | 7.53B |
| Q2 FY2015 | 30 Jun 2015 | 1.38 | 10.44B | 7.55B |
| Q1 FY2015 | 31 Mar 2015 | 1.47 | 11.07B | 7.53B |
| Q4 FY2014 | 31 Dec 2014 | 1.31 | 9.72B | 7.44B |
| Q3 FY2014 | 30 Sept 2014 | 1.20 | 8.80B | 7.31B |
| Q2 FY2014 | 30 Jun 2014 | 1.18 | 8.45B | 7.19B |
| Q1 FY2014 | 31 Mar 2014 | 1.17 | 8.34B | 7.10B |
| Q4 FY2013 | 31 Dec 2013 | 1.09 | 7.82B | 7.15B |
| Q3 FY2013 | 30 Sept 2013 | 1.29 | 9.24B | 7.16B |
| Q2 FY2013 | 30 Jun 2013 | 1.28 | 9.23B | 7.23B |
| Q1 FY2013 | 31 Mar 2013 | 1.22 | 8.90B | 7.32B |
| Q4 FY2012 | 31 Dec 2012 | 1.24 | 9.25B | 7.47B |
| Q3 FY2012 | 30 Sept 2012 | 1.33 | 10.07B | 7.57B |
| Q2 FY2012 | 30 Jun 2012 | 1.24 | 9.49B | 7.63B |
| Q1 FY2012 | 31 Mar 2012 | 1.27 | 9.68B | 7.63B |
| Q4 FY2011 | 31 Dec 2011 | 1.22 | 9.19B | 7.51B |
| Q3 FY2011 | 30 Sept 2011 | 1.04 | 7.79B | 7.46B |
| Q2 FY2011 | 30 Jun 2011 | 1.26 | 9.31B | 7.41B |
| Q1 FY2011 | 31 Mar 2011 | 1.26 | 9.32B | 7.39B |
| Q4 FY2010 | 31 Dec 2010 | 1.18 | 8.72B | 7.37B |
| Q3 FY2010 | 30 Sept 2010 | 1.18 | 8.74B | 7.39B |
| Q2 FY2010 | 30 Jun 2010 | 1.20 | 8.90B | 7.43B |
| Q1 FY2010 | 31 Mar 2010 | 1.41 | 10.50B | 7.45B |
| Q4 FY2009 | 31 Dec 2009 | 1.46 | 10.88B | 7.46B |
| Q3 FY2009 | 30 Sept 2009 | 1.30 | 9.66B | 7.41B |
| Q2 FY2009 | 30 Jun 2009 | 1.42 | 10.45B | 7.34B |
| Q1 FY2009 | 31 Mar 2009 | 1.24 | 8.99B | 7.27B |
| Q4 FY2008 | 31 Dec 2008 | 1.36 | 9.83B | 7.25B |
| Q3 FY2008 | 30 Sept 2008 | 1.40 | 10.07B | 7.22B |
| Q2 FY2008 | 30 Jun 2008 | 1.32 | 9.43B | 7.16B |
| Q1 FY2008 | 31 Mar 2008 | 1.26 | 8.79B | 6.96B |
| Q4 FY2007 | 31 Dec 2007 | 1.53 | 10.24B | 6.70B |
| Q3 FY2007 | 30 Sept 2007 | 1.72 | 11.15B | 6.48B |
| Q2 FY2007 | 30 Jun 2007 | 1.58 | 9.95B | 6.30B |
| Q1 FY2007 | 31 Mar 2007 | 1.54 | 9.64B | 6.24B |
| Q4 FY2006 | 31 Dec 2006 | 1.63 | 10.25B | 6.27B |
| Q3 FY2006 | 30 Sept 2006 | 1.96 | 12.06B | 6.16B |
| Q2 FY2006 | 30 Jun 2006 | 2.00 | 11.86B | 5.95B |
| Q1 FY2006 | 31 Mar 2006 | 1.77 | 10.18B | 5.74B |
| Q4 FY2005 | 31 Dec 2005 | 1.86 | 10.21B | 5.50B |
| Q3 FY2005 | 30 Sept 2005 | 1.91 | 10.24B | 5.35B |
| Q2 FY2005 | 30 Jun 2005 | 2.05 | 10.79B | 5.27B |
| Q1 FY2005 | 31 Mar 2005 | 2.04 | 10.60B | 5.19B |
| Q4 FY2004 | 31 Dec 2004 | 1.87 | 9.57B | 5.13B |
| Q3 FY2004 | 30 Sept 2004 | 1.77 | 8.93B | 5.05B |
| Q2 FY2004 | 30 Jun 2004 | 1.76 | 8.75B | 4.98B |
| Q1 FY2004 | 31 Mar 2004 | 1.74 | 8.54B | 4.90B |
| Q4 FY2003 | 31 Dec 2003 | 1.59 | 7.54B | 4.74B |
| Q3 FY2003 | 30 Sept 2003 | 1.39 | 6.35B | 4.57B |
| Q2 FY2003 | 30 Jun 2003 | 1.52 | 6.70B | 4.41B |
| Q1 FY2003 | 31 Mar 2003 | 1.40 | 5.97B | 4.25B |
| Q4 FY2002 | 31 Dec 2002 | 1.34 | 5.52B | 4.11B |
| Q3 FY2002 | 30 Sept 2002 | 1.50 | 5.96B | 3.98B |
| Q2 FY2002 | 30 Jun 2002 | 2.03 | 7.77B | 3.83B |
| Q1 FY2002 | 31 Mar 2002 | 2.14 | 7.90B | 3.69B |
| Q4 FY2001 | 31 Dec 2001 | 1.88 | 6.83B | 3.63B |
| Q3 FY2001 | 30 Sept 2001 | 1.55 | 5.51B | 3.55B |
| Q2 FY2001 | 30 Jun 2001 | 1.98 | 6.93B | 3.50B |
| Q1 FY2001 | 31 Mar 2001 | 1.18 | 4.08B | 3.45B |
| Q4 FY2000 | 31 Dec 2000 | 1.88 | 6.44B | 3.42B |
| Q3 FY2000 | 30 Sept 2000 | 1.52 | 5.16B | 3.40B |
| Q2 FY2000 | 30 Jun 2000 | 1.05 | 3.33B | 3.16B |
| Q1 FY2000 | 31 Mar 2000 | 0.65 | 1.75B | 2.68B |
| Q4 FY1999 | 31 Dec 1999 | 0.61 | 1.35B | 2.21B |
| Q3 FY1999 | 30 Sept 1999 | 0.54 | 940.00M | 1.75B |
| Q2 FY1999 | 30 Jun 1999 | 0.54 | 814.58M | 1.50B |
| Q1 FY1999 | 31 Mar 1999 | 0.45 | 660.88M | 1.47B |
| Q4 FY1998 | 31 Dec 1998 | 0.36 | 526.88M | 1.46B |
| Q3 FY1998 | 30 Sept 1998 | 0.34 | 503.86M | 1.46B |
| Q2 FY1998 | 30 Jun 1998 | 0.44 | 649.11M | 1.47B |
| Q1 FY1998 | 31 Mar 1998 | 0.33 | 504.00M | 1.51B |
| Q4 FY1997 | 31 Dec 1997 | 0.32 | 484.94M | 1.53B |
| Q3 FY1997 | 30 Sept 1997 | 0.33 | 507.60M | 1.55B |
| Q2 FY1997 | 30 Jun 1997 | 0.38 | 594.77M | 1.58B |
| Q1 FY1997 | 31 Mar 1997 | — | 425.14M | — |
| Q4 FY1996 | 31 Dec 1996 | — | 436.97M | — |
| Q3 FY1996 | 30 Sept 1996 | — | 404.60M | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,Dividend yield,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about Quest Diagnostics's P/S ratio
Source: Financial Modeling Prep